Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractEffect of a brood pheromone on honeybee hypopharyngeal glands    Next AbstractDegradation of the S. frugiperda peritrophic matrix by an inducible maize cysteine protease »

ERJ Open Res


Title:Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
Author(s):Mohan D; Keir HR; Richardson H; Mayhew D; Boyer J; van der Schee MP; Allsworth MD; Miller BE; Tal-Singer R; Chalmers JD;
Address:"GSK R&D, Collegeville, PA, USA. Ninewells Clinical Research Centre, University of Dundee, Dundee, UK. Owlstone Medical, Cambridge, UK"
Journal Title:ERJ Open Res
Year:2021
Volume:20211004
Issue:4
Page Number: -
DOI: 10.1183/23120541.00253-2021
ISSN/ISBN:2312-0541 (Print) 2312-0541 (Electronic) 2312-0541 (Linking)
Abstract:"BACKGROUND: Breath analysis is a burgeoning field, with interest in volatile organic compounds (VOCs) as a noninvasive diagnostic tool or an outcome measure, but no randomised controlled trials (RCTs) have yet evaluated this technology in a clinical trial longitudinally. In a pilot RCT, our exploratory objectives were feasibility of measuring VOCs via multiple techniques, assessing relationships between VOCs and Haemophilus colonisation and whether CXCR2 antagonism with danirixin altered lung microbiome composition in individuals with COPD. METHOD: 43 participants had VOCs and sputum biomarkers evaluated. VOCs and induced sputum were collected after 6 h of fasting at screening and at days 1, 7 and 14. VOCs were analysed via gas chromatography mass spectrometry (GC-MS), field asymmetric ion mobility spectrometry (FAIMS) and eNose. The primary outcome for these analyses was the relationship between VOCs and Haemophilus abundance determined by 16S rRNA sequencing. RESULTS: A joint-effects model demonstrated a modest relationship between four exhaled VOCs and Haemophilus relative abundance (R(2)=0.55) measured only by GC-MS, but not as measured using gas chromtaography FAIMS or eNose. There was considerable variability in absolute quantities of individual VOCs longitudinally. CONCLUSIONS: VOC measurement in clinical trials to identify subsets of COPD is feasible, but assessment of new VOC technologies must include concurrent GC-MS validation. Further work to standardise collection of VOCs and measuring a background or 'housekeeper' VOC is required to understand and normalise individual VOC quantities"
Keywords:
Notes:"PubMed-not-MEDLINEMohan, Divya Keir, Holly R Richardson, Hollian Mayhew, David Boyer, Joseph van der Schee, Marc P Allsworth, Max D Miller, Bruce E Tal-Singer, Ruth Chalmers, James D eng England 2021/10/08 ERJ Open Res. 2021 Oct 4; 7(4):00253-2021. doi: 10.1183/23120541.00253-2021. eCollection 2021 Oct"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-11-2024